NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Activity
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

49 hedge funds and large institutions have $6.65M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 3 closing their positions.

Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
10
Closed
3
Calls
$44K
Puts
$233K
Net Calls
-$189K
Net Calls Change
+$506K

Top Buyers

1
SM
1
Sabby Management
Florida
$1.74M
2
B
2
Bailard
California
$674K
3
VKH
3
Virtu KCG Holdings
New York
$59K
4
TSS
4
Two Sigma Securities
New York
$38K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$101K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.18M
2
PNC Financial Services Group
2
PNC Financial Services Group
Pennsylvania
$30K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$88K
4
GBA
4
Garrison Bradford & Associates
New York
$114K
5
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
– – -3 Closed
PCA
52
Peddock Capital Advisors
Massachusetts
– – -1 Closed
Wells Fargo
53
Wells Fargo
California
– – – –
ACP
54
Acuta Capital Partners
California
– – – –
1 2
3